AngioScore is a clinical stage medical device company based in Alameda, California. AngioScore is the developer and manufacturer of AngioSculpt, a line of innovative coronary angioplasty catheters. An AngioSculpt catheter comprises an angioplasty balloon surrounded by nitinol wires that score arterial lesions as the balloon expands. The potential market encompasses more than half of the 2 million angioplasties performed annually. Intended uses include dilatation prior to delivery of a drug eluting stent, and dilatation of fibrocalcific lesions, in stent restenosis, and small vessels.


Date Type Amount Investors Valuation
10/09/07 Series E 30M California Technology Ventures, Innomed Ventures, Psilos Group Management, QuestMark Partners, Telegraph Hill Partners, UV Partners, Link-agene Unknown


Nimrod Tzori (CTO)

Feridun Ozdil (Chief Scientific Officer)

Gary Lazar (Board Member)

Thomas Raffin (Board Member)

Gary Gershony (Chief Medical Officer)

View more details about all 17 people at AngioScore